Displaying items by tag:

A $2.9 million study aims to lower the risk of pregnant women becoming infected with cytomegalovirus, a virus that can lead to long-term health problems for babies.

The RAC serves a critical role in the oversight of federally funded research involving recombinant DNA and advises the NIH director on such matters.